Pharmaceutical Business review

Dynamic notifies Nasdaq of merger with GeoPharma

Additionally, Dynamic has repaid Laurus Master Fund, approximately $5.9 million in full satisfaction of all obligations to Laurus.

Mandeep Taneja, president and CEO, said: “It was a pleasure working with Laurus over the last few years. Their support gave us the flexibility, room, and capital required to help increase our revenue from approximately $16 million in our fiscal year ending in March of 2005 to approximately $56.8 million in our fiscal year ending in March of 2007.”